Search details
1.
Cardiovascular disease and cancer: shared risk factors and mechanisms.
Nat Rev Cardiol
; 2024 Apr 10.
Article
in English
| MEDLINE | ID: mdl-38600368
2.
Phase II Trial of Combination Nab-paclitaxel and Gemcitabine in Non-squamous Non-small Cell Lung Cancer After Progression on Platinum and Pemetrexed.
Clin Lung Cancer
; 23(4): e310-e316, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35393247
3.
Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung Cancer.
Cancer Discov
; 6(9): 1006-21, 2016 09.
Article
in English
| MEDLINE | ID: mdl-27312177
4.
Co-clinical trials demonstrate superiority of crizotinib to chemotherapy in ALK-rearranged non-small cell lung cancer and predict strategies to overcome resistance.
Clin Cancer Res
; 20(5): 1204-1211, 2014 Mar 01.
Article
in English
| MEDLINE | ID: mdl-24327273
5.
Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expression.
Cancer Cell
; 25(5): 590-604, 2014 May 12.
Article
in English
| MEDLINE | ID: mdl-24794706
6.
Inhibition of KRAS-driven tumorigenicity by interruption of an autocrine cytokine circuit.
Cancer Discov
; 4(4): 452-65, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-24444711
7.
Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors.
Cancer Discov
; 3(12): 1355-63, 2013 Dec.
Article
in English
| MEDLINE | ID: mdl-24078774
Results
1 -
7
de 7
1
Next >
>>